All the students of the Master's Degree in research, development and Medication Innovation (MIDI) of the School of Pharmacy and Nutrition of the University of Navarra find work within 10 months of completing their training, of which 84% succeeded within six months. "Although they make reference letter to the status labor of the 30 students of the class of 2019, the data of this last report of employability reflect the general insertion that the different promotions of the Master's Degreehave had for years ", points out Ariane Vettorazzi, coordinator of the program.

The career prospects of the students is thus placed in a variety of companies, whether biotech companies, international and national "big pharmas" or companies focused on consultancy service or services to third parties. Moreover, as Vetorazzi points out, since Master's Degree is focused on research, "a large number of graduates end up in clinical and preclinical positions at research , while others start in programs at doctorate". 

In fact, half of the MIDI students are engaged in issues related to research and development, clinical and preclinical, while the rest find work at Departments quality, production, registries, modeling, toxicology, etc.

According to report, the companies hosting students in the class of 2019 are: Idifarma, Navarrabiomed, GSKI, Azierta, Clínica Universidad de Navarra, 3P Biopharmaceuticals, Hoffman-La Roche, Boehringer Ingelheim, Geiser Pharma, Cinfa, Cyndea Pharma, FAES Farma, Famar Healthcare, Rovi, A3Z Advanced, Prisma, DNA Catcher, Viscofan, UK Dementia Research Institute and the University of Navarra itself.